Additionally, our data on the association between TNFRSF13B rs11078355A>G genotypes and TACI membranous expression on CLL cells seems to be worthy of further investigation in diseases where blocking of APRIL-TACI interactions is considered as a treatment option. The gene discussed is TNFRSF13B; the disease is B-cell chronic lymphocytic leukemia.